Intervention

Young TIL

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting2

Common conditions10

Lead sponsors shown1

Clinical trials

2 shown

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerNCT02133196 · 2014-10-23

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerNCT01174121 · 2010-08-26

Common conditions

Adenocarcinoma1 Adenosquamous Carcinoma1 Advanced Non-Small Cell Lung Cancer1 Advanced NSCLC1 Metastatic Breast Carcinoma1 Metastatic Colorectal Cancer1 Metastatic Endocrine Tumors/ Neuroendocrine Tumors1 Metastatic Ovarian Cancer1 Metastatic Pancreatic Cancer1 Squamous Cell Carcinoma1

Leading sponsors

National Cancer Institute (NCI)2

Trial status mix

RECRUITING2

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.